Suppr超能文献

实体瘤化疗诱导治疗中的个体化间期缩短(作者译)

[Individualized interval shortening in the chemotherapeutic induction treatment of solid tumors (author's transl)].

作者信息

Seeber S, Higi M, Niederle N, Schmidt C G

出版信息

Dtsch Med Wochenschr. 1981 Dec 25;106(51-52):1741-4. doi: 10.1055/s-2008-1070588.

Abstract

Sequential chemotherapy with vinblastin and bleomycin, as well as adriamycin and cis-platin, was administered to 29 patients with disseminated malignant testicular teratoma. In order to intensify the induction phase, the intervals between drug administrations were individually shortened, with the next course of treatment following directly after the phase of critical leucocyte depression. This method was pursued over four courses of chemotherapy without dose reduction, followed by courses of chemotherapy in a conventional three-weekly rhythm. A response was obtained in 28 patients, 18 of them achieving complete remission. Taking into consideration unfavourable prognostic factors in the treatment group, this result is better than after the same chemotherapy at three-weekly intervals. Induction treatment adapted to leucocyte response carries with it the risk of higher toxicity, but this would seem to be acceptable in view of the improved long-term prognosis. This or similar intensification of the first treatment phase, for a long time used with leukaemias, could also be considered in the management of various chemotherapy-sensitive solid tumours, especially in younger patients.

摘要

对29例播散性恶性睾丸畸胎瘤患者采用长春碱和博来霉素以及阿霉素和顺铂进行序贯化疗。为强化诱导期,药物给药间隔个体化缩短,在下一疗程治疗直接在严重白细胞减少期之后进行。该方法在四个化疗疗程中持续进行且不降低剂量,随后按常规每三周一次的节奏进行化疗疗程。28例患者有反应,其中18例实现完全缓解。考虑到治疗组中不利的预后因素,该结果优于每三周进行一次相同化疗后的结果。根据白细胞反应调整诱导治疗存在更高毒性的风险,但鉴于长期预后改善,这似乎是可以接受的。这种或类似的强化第一治疗阶段的方法,长期以来用于白血病治疗,在各种化疗敏感实体瘤的管理中也可考虑,尤其是在年轻患者中。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验